0001127602-11-033121.txt : 20111222 0001127602-11-033121.hdr.sgml : 20111222 20111222190450 ACCESSION NUMBER: 0001127602-11-033121 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111220 FILED AS OF DATE: 20111222 DATE AS OF CHANGE: 20111222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PYOTT DAVID E I CENTRAL INDEX KEY: 0001051578 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10269 FILM NUMBER: 111278692 MAIL ADDRESS: STREET 1: C/O ALLERGAN STREET 2: 2525 DUPONT DRIVE CITY: IRVINE STATE: CA ZIP: 92612 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALLERGAN INC CENTRAL INDEX KEY: 0000850693 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 951622442 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2525 DUPONT DRIVE CITY: IRVINE STATE: CA ZIP: 92612 BUSINESS PHONE: 7142464500 MAIL ADDRESS: STREET 1: P.O. BOX 19534 CITY: IRVINE STATE: CA ZIP: 92713-9534 4 1 form4.xml PRIMARY DOCUMENT X0304 4 2011-12-20 0000850693 ALLERGAN INC AGN 0001051578 PYOTT DAVID E I 2525 DUPONT DRIVE IRVINE CA 92612 1 1 Chairman, President and CEO Common Stock 2011-12-20 4 M 0 250000 32.3937 A 456923 I By Living Trust Common Stock 2011-12-20 4 S 0 250000 85.9068 D 206923 I By Living Trust Common Stock 2011-12-21 4 M 0 250000 32.3937 A 456923 I By Living Trust Common Stock 2011-12-21 4 S 0 250000 86.0512 D 206923 I By Living Trust Common Stock 2011-12-22 4 M 0 66754 32.3937 A 273677 I By Living Trust Common Stock 2011-12-22 4 S 0 66754 86.3453 D 206923 I By Living Trust Common Stock 31252 D Common Stock 2167.6579 I By 401(k) Trust Common Stock 2880.125 I By Esop Trust Employee Stock Option (Right to Buy) 32.3937 2011-12-20 4 M 0 250000 0 D 2012-04-24 Common Stock 250000 316754 I By Living Trust Employee Stock Option (Right to Buy) 32.3937 2011-12-21 4 M 0 250000 0 D 2012-04-24 Common Stock 250000 66754 I By Living Trust Employee Stock Option (Right to Buy) 32.3937 2011-12-22 4 M 0 66754 0 D 2012-04-24 Common Stock 66754 0 I By Living Trust The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 3, 2011. The price reported in this Form 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $85.90 to $85.96, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holders of Allergan, Inc., or the staff of the Securities Exchange Commission, the full information regarding the number of shares sold at each price range sert forth in this footnote. The price reported in comlumn 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $85.90 to $86.72, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities Exchange Commission, upon request, the full information regarding the number of shares sold at each price within the range set forth in this footnote. The price reported in column 4 is the weighted average price. These shares were sold in multiple transaction at prices ranging from $85.90 to $87.11, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities Exchange Commission, upon request, the full information regarding the number of shares sold at each price within the range set forth in this footnote. David and Julianna Pyott Living Trust dated June 14, 1999, in which the reporting person has a pecuniary interest and of which the reporting person and his spouse are each trustees. Shares allocated to reporting person's SIP account as of reporting date. Shares allocated to the reporting person's ESOP account as of reporting date. The option became exercisable in four equal annual installments beginning 4/24/2003. /s/ Matthew J. Maletta, attorney-in-fact for David E.I. Pyott 2011-12-22